東華大學圖書館 |

Neuroimaging pharmacopoeia

Record Type:	Electronic resources : Monograph/item
Title/Author:	Neuroimaging pharmacopoeia/ edited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer.
other author:	Ginat, Daniel Thomas.
Published:	Cham :Springer International Publishing : : 2022.,
Description:	ix, 448 p. :ill., digital ;24 cm.
[NT 15003449]:	PART I: Drugs and Alcohol -- 1. Tobacco -- 2. Alcohol -- 3. Methanol -- 4. Cannabis (Marijuana) -- 5. Synthetic Cannabinoids (spice/K2 preparations) -- 6. Crack and Cocaine -- 7. Amphetamines -- 8. Opioids -- 9. Betel Nuts -- 10. Licorice -- 11. Centella asiatica -- PART II: Contrast Agents -- 12. Iodinated Contrast Agents -- 13. Gadolinium-Based Contrast Agents -- 14. Ferumoxytol -- 15. Pantopaque (Myodil, Iodophenylundecylic Acid) -- 16. Thorium Dioxide (Thorotrast) -- PART III: Chemotherapy -- 17. Temozolamide (Temodar) -- 18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) -- 19. Methotrexate -- 20. 5-Fluorouracil -- 21. L-Asparaginase (Elspar/Erwinase) -- 22. Calcineurin Inhibitors -- 23. Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) -- PART IV: Anti-cancer Immunotherapy -- 25. Ipilimumab (MDX-010, Yervoy) -- 26. Bevacizumab (Avastin) -- 27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) -- PART V: Antiobiotics, Antiviral Agents, and Vaccines -- 28. Metronidazole (Flagyl) -- 29. Iodoform -- 30. Isoniazid -- 31. Highly Active Antiretroviral Therapy (HAART) -- 32. Vaccines -- PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents -- 33. Dilantin (Phenytoin Sodium) -- 34. Valproic Acid (Sodium Valproate, Depakote) -- 35. Vigabatrin (Sabril) -- 36. Lithium -- 37. Neuroleptics -- PART VII: Anesthetic and Sedative Agents -- 38. Barbiturates (Pentobarbital) -- 39. Nitrous Oxide (N2O) -- 40. Propofol -- PART VIII: Hemostatic and Vasoactive Agents -- 41. Embolic Agents -- 42. Aspirin and Plavix/Clopidogrel -- 43. Warfarin (Coumadin) -- 44. Heparin -- 45. Tissue Plasminogen Activator (tPA) -- 46. Oxidized Cellulose -- 47. Nasal Decongestants -- PART IX: Cardiovascular Support Agents -- 48. Supplemental Oxygen -- 49. Hypertonic Saline -- 50. Mannitol (1,2,3,4,5,6-Hexanehexol) -- 51. Triple H Therapy -- 52. Angiotensin Converting Enzyme (ACE) Inhibitors -- 53. Acetazolamide (Diamox) -- 54. Amiodarone -- PART X: Anti-inflammatory Agents -- 55. Acetominophen (Tylenol, Paracetamol) -- 56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals) -- 57. Synthetic Corticosteroids -- PART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs -- 58. Manganese in Total Parenteral Nutrition -- 59. Zinc Oxide (ZnO) -- 60. Insulin -- 61. Bisphosphonates -- 62. Recombinant Human Bone Morphogenetic Protein -- 63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid) -- 64. Topical Prostaglandin Analogues -- 65. Oral Contraceptives (Estrogen and Progestin) -- 66. Fish Oil -- PART XII: Injectable Filler Agents -- 67. Calcium hydroxyapatite-based Fillers -- 68. Hyaluronic Acid-based Fillers -- 69. Injectable Silicone Oil.
Contained By:	Springer Nature eBook
Subject:	Nervous system - Case studies. - Imaging -
Online resource:	https://doi.org/10.1007/978-3-031-08774-5
ISBN:	9783031087745

Neuroimaging pharmacopoeia
Neuroimaging pharmacopoeia[electronic resource] /edited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer. - Second edition. - Cham :Springer International Publishing :2022. - ix, 448 p. :ill., digital ;24 cm.

PART I: Drugs and Alcohol -- 1. Tobacco -- 2. Alcohol -- 3. Methanol -- 4. Cannabis (Marijuana) -- 5. Synthetic Cannabinoids (spice/K2 preparations) -- 6. Crack and Cocaine -- 7. Amphetamines -- 8. Opioids -- 9. Betel Nuts -- 10. Licorice -- 11. Centella asiatica -- PART II: Contrast Agents -- 12. Iodinated Contrast Agents -- 13. Gadolinium-Based Contrast Agents -- 14. Ferumoxytol -- 15. Pantopaque (Myodil, Iodophenylundecylic Acid) -- 16. Thorium Dioxide (Thorotrast) -- PART III: Chemotherapy -- 17. Temozolamide (Temodar) -- 18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) -- 19. Methotrexate -- 20. 5-Fluorouracil -- 21. L-Asparaginase (Elspar/Erwinase) -- 22. Calcineurin Inhibitors -- 23. Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) -- PART IV: Anti-cancer Immunotherapy -- 25. Ipilimumab (MDX-010, Yervoy) -- 26. Bevacizumab (Avastin) -- 27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) -- PART V: Antiobiotics, Antiviral Agents, and Vaccines -- 28. Metronidazole (Flagyl) -- 29. Iodoform -- 30. Isoniazid -- 31. Highly Active Antiretroviral Therapy (HAART) -- 32. Vaccines -- PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents -- 33. Dilantin (Phenytoin Sodium) -- 34. Valproic Acid (Sodium Valproate, Depakote) -- 35. Vigabatrin (Sabril) -- 36. Lithium -- 37. Neuroleptics -- PART VII: Anesthetic and Sedative Agents -- 38. Barbiturates (Pentobarbital) -- 39. Nitrous Oxide (N2O) -- 40. Propofol -- PART VIII: Hemostatic and Vasoactive Agents -- 41. Embolic Agents -- 42. Aspirin and Plavix/Clopidogrel -- 43. Warfarin (Coumadin) -- 44. Heparin -- 45. Tissue Plasminogen Activator (tPA) -- 46. Oxidized Cellulose -- 47. Nasal Decongestants -- PART IX: Cardiovascular Support Agents -- 48. Supplemental Oxygen -- 49. Hypertonic Saline -- 50. Mannitol (1,2,3,4,5,6-Hexanehexol) -- 51. Triple H Therapy -- 52. Angiotensin Converting Enzyme (ACE) Inhibitors -- 53. Acetazolamide (Diamox) -- 54. Amiodarone -- PART X: Anti-inflammatory Agents -- 55. Acetominophen (Tylenol, Paracetamol) -- 56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals) -- 57. Synthetic Corticosteroids -- PART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs -- 58. Manganese in Total Parenteral Nutrition -- 59. Zinc Oxide (ZnO) -- 60. Insulin -- 61. Bisphosphonates -- 62. Recombinant Human Bone Morphogenetic Protein -- 63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid) -- 64. Topical Prostaglandin Analogues -- 65. Oral Contraceptives (Estrogen and Progestin) -- 66. Fish Oil -- PART XII: Injectable Filler Agents -- 67. Calcium hydroxyapatite-based Fillers -- 68. Hyaluronic Acid-based Fillers -- 69. Injectable Silicone Oil.

This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book's closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike.

ISBN: 9783031087745

Standard No.: 10.1007/978-3-031-08774-5doiSubjects--Topical Terms:

1092209
Nervous system
--Imaging--Case studies.

LC Class. No.: RC349.D52

Dewey Class. No.: 616.80475

Neuroimaging pharmacopoeia
LDR:04773nmm a2200337 a 4500 001 2305907
003 DE-He213
005 20221129152348.0
006 m d
007 cr nn 008maaau
008 230409s2022 sz s 0 eng d
020 $a 9783031087745 $q (electronic bk.)
020 $a 9783031087738 $q (paper)
024 7 $a 10.1007/978-3-031-08774-5 $2 doi
035 $a 978-3-031-08774-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC349.D52
072 7 $a MMP $2 bicssc
072 7 $a MED056000 $2 bisacsh
072 7 $a MKS $2 thema
082 0 4 $a 616.80475 $2 23
090 $a RC349.D52 $b N494 2022
245 0 0 $a Neuroimaging pharmacopoeia $h [electronic resource] / $c edited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer.
250 $a Second edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a ix, 448 p. : $b ill., digital ; $c 24 cm.
505 0 $a PART I: Drugs and Alcohol -- 1. Tobacco -- 2. Alcohol -- 3. Methanol -- 4. Cannabis (Marijuana) -- 5. Synthetic Cannabinoids (spice/K2 preparations) -- 6. Crack and Cocaine -- 7. Amphetamines -- 8. Opioids -- 9. Betel Nuts -- 10. Licorice -- 11. Centella asiatica -- PART II: Contrast Agents -- 12. Iodinated Contrast Agents -- 13. Gadolinium-Based Contrast Agents -- 14. Ferumoxytol -- 15. Pantopaque (Myodil, Iodophenylundecylic Acid) -- 16. Thorium Dioxide (Thorotrast) -- PART III: Chemotherapy -- 17. Temozolamide (Temodar) -- 18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) -- 19. Methotrexate -- 20. 5-Fluorouracil -- 21. L-Asparaginase (Elspar/Erwinase) -- 22. Calcineurin Inhibitors -- 23. Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) -- PART IV: Anti-cancer Immunotherapy -- 25. Ipilimumab (MDX-010, Yervoy) -- 26. Bevacizumab (Avastin) -- 27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) -- PART V: Antiobiotics, Antiviral Agents, and Vaccines -- 28. Metronidazole (Flagyl) -- 29. Iodoform -- 30. Isoniazid -- 31. Highly Active Antiretroviral Therapy (HAART) -- 32. Vaccines -- PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents -- 33. Dilantin (Phenytoin Sodium) -- 34. Valproic Acid (Sodium Valproate, Depakote) -- 35. Vigabatrin (Sabril) -- 36. Lithium -- 37. Neuroleptics -- PART VII: Anesthetic and Sedative Agents -- 38. Barbiturates (Pentobarbital) -- 39. Nitrous Oxide (N2O) -- 40. Propofol -- PART VIII: Hemostatic and Vasoactive Agents -- 41. Embolic Agents -- 42. Aspirin and Plavix/Clopidogrel -- 43. Warfarin (Coumadin) -- 44. Heparin -- 45. Tissue Plasminogen Activator (tPA) -- 46. Oxidized Cellulose -- 47. Nasal Decongestants -- PART IX: Cardiovascular Support Agents -- 48. Supplemental Oxygen -- 49. Hypertonic Saline -- 50. Mannitol (1,2,3,4,5,6-Hexanehexol) -- 51. Triple H Therapy -- 52. Angiotensin Converting Enzyme (ACE) Inhibitors -- 53. Acetazolamide (Diamox) -- 54. Amiodarone -- PART X: Anti-inflammatory Agents -- 55. Acetominophen (Tylenol, Paracetamol) -- 56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals) -- 57. Synthetic Corticosteroids -- PART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs -- 58. Manganese in Total Parenteral Nutrition -- 59. Zinc Oxide (ZnO) -- 60. Insulin -- 61. Bisphosphonates -- 62. Recombinant Human Bone Morphogenetic Protein -- 63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid) -- 64. Topical Prostaglandin Analogues -- 65. Oral Contraceptives (Estrogen and Progestin) -- 66. Fish Oil -- PART XII: Injectable Filler Agents -- 67. Calcium hydroxyapatite-based Fillers -- 68. Hyaluronic Acid-based Fillers -- 69. Injectable Silicone Oil.
520 $a This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book's closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike.
650 0 $a Nervous system $x Imaging $v Case studies. $3 1092209
650 0 $a Nervous system $x Diseases $x Diagnosis $v Case studies. $3 3609431
650 0 $a Nervous system $x Diseases $x Treatment. $3 820072
650 0 $a Pharmacopoeias. $3 820333
650 0 $a Diagnosis, Differential. $3 591095
700 1 $a Ginat, Daniel Thomas. $3 2133663
700 1 $a Small, Juan E. $3 2134915
700 1 $a Schaefer, Pamela W. $3 3609430
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-08774-5
950 $a Medicine (SpringerNature-11650)